| Typicality: | 0.420 |
| Saliency: | 0.299 |
| for drug companies | 9 | transitive-object |
| highly | 6 | degree |
| in terms of volume of sales | 6 | other |
| vaccine → be → profitable | 19 |
| vaccine → make → money | 5 |
| vaccine → make → profit | 3 |
| negative | neutral | positive |
| 0.462 | 0.353 | 0.184 |
| Raw frequency | 27 |
| Normalized frequency | 0.299 |
| Modifier score | 0.900 |
| Perplexity | 135.135 |